NCV

Certain Virtus Closed-End Funds Announce Date of Shareholder Meetings

Retrieved on: 
星期四, 三月 23, 2023

Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), Virtus Convertible & Income 2024 Target Term Fund (NYSE: CBH), Virtus Convertible & Income Fund (NYSE: NCV), Virtus Convertible & Income Fund II (NYSE: NCZ), Virtus Diversified Income & Convertible Fund (NYSE: ACV), Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ), Virtus Equity & Convertible Income Fund (NYSE: NIE), and Virtus Stone Harbor Emerging Markets Total Income Fund (NYSE: EDI) have announced that they will hold a virtual joint meeting of shareholders on May 22, 2023 at 1 p.m. EDT.

Key Points: 
  • Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), Virtus Convertible & Income 2024 Target Term Fund (NYSE: CBH), Virtus Convertible & Income Fund (NYSE: NCV), Virtus Convertible & Income Fund II (NYSE: NCZ), Virtus Diversified Income & Convertible Fund (NYSE: ACV), Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ), Virtus Equity & Convertible Income Fund (NYSE: NIE), and Virtus Stone Harbor Emerging Markets Total Income Fund (NYSE: EDI) have announced that they will hold a virtual joint meeting of shareholders on May 22, 2023 at 1 p.m. EDT.
  • Virtus Stone Harbor Emerging Markets Income Fund (NYSE: EDF) will hold its virtual meeting of shareholders on May 22, 2023 at 1:30 p.m. EDT.
  • Each fund’s Board of Trustees has fixed the close of business on March 31, 2023 as the record date for the determination of shareholders who will be entitled to receive notice of, and vote at, the meetings.
  • For more information on the Funds, contact Shareholder Services at (866) 270-7788, by email at [email protected] , or through the closed-end funds section of virtus.com .

Rhythmlink Announces Investment Partnership With Graham Partners

Retrieved on: 
星期五, 三月 17, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses.

Key Points: 
  • Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses.
  • As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for.
  • “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder.
  • Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices.

onsemi extends Bluetooth Low Energy MCU Family for Automotive Wireless Applications

Retrieved on: 
星期二, 三月 14, 2023

onsemi (Nasdaq: ON), a leader in intelligent power and sensing technologies, today announced an ultra-low power automotive-grade wireless microcontroller with Bluetooth® Low Energy connectivity.

Key Points: 
  • onsemi (Nasdaq: ON), a leader in intelligent power and sensing technologies, today announced an ultra-low power automotive-grade wireless microcontroller with Bluetooth® Low Energy connectivity.
  • The new microcontroller also addresses heightened security concerns resulting from more sensors and with that more possible attack vectors.
  • While the lists of sensors and general functionality in Tire Monitoring Systems (TMS) and other sensing applications continue to grow, the power consumption budget has not increased.
  • Along with 24/7 development community support, onsemi makes it easy to design in.

Next Century Ventures, venture capital arm of NEXEN TIRE, announces strategic investment in Automotus, a U.S.-based curbside management startup

Retrieved on: 
星期三, 三月 8, 2023

Automotus, founded in U.S. in 2017, collaborates with government, institutions, and mobility innovators across the country to test and evaluate curbside management techniques in order to minimize curbside congestion emissions and expedite developments in zero-emission vehicles.

Key Points: 
  • Automotus, founded in U.S. in 2017, collaborates with government, institutions, and mobility innovators across the country to test and evaluate curbside management techniques in order to minimize curbside congestion emissions and expedite developments in zero-emission vehicles.
  • Together with NEXEN TIRE, other investors include Techstars, a top early stage investor and incubator, the Los Angeles Cleantech Incubator (LACI), and QUAKE Capital Partners.
  • "We are incredibly happy to have Next Century Ventures participate in this investment round.
  • "NCV believes in Automotus' vision and looks forward to working actively with the firm to support its strategic goals."

Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares

Retrieved on: 
星期二, 二月 28, 2023

Virtus Convertible & Income Fund (NYSE: NCV), announced today that it has declared a $0.3515625 per share cash distribution payable on March 31, 2023 to Series A cumulative preferred shareholders of record on March 13, 2023.

Key Points: 
  • Virtus Convertible & Income Fund (NYSE: NCV), announced today that it has declared a $0.3515625 per share cash distribution payable on March 31, 2023 to Series A cumulative preferred shareholders of record on March 13, 2023.
  • The Series A Cumulative Preferred Shares, which trade on the New York Stock Exchange under the symbol NCV PR A, are rated “A” by Fitch Ratings and have an annual dividend rate of $1.40625 per share.
  • The 4,000,000 Series A Cumulative Preferred Shares were issued September 20, 2018 at $25.00 per share and pay distributions quarterly.
  • The Series A Cumulative Preferred Shares will be callable at any time at the liquidation value of $25.00 per share plus accrued dividends from and after the expiration of a five-year non-call period on September 20, 2023.

Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology

Retrieved on: 
星期二, 二月 28, 2023

SHERMAN, Texas, Feb. 28, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.

Key Points: 
  • SHERMAN, Texas, Feb. 28, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.
  • Dr. Matus earned a medical degree from the School of Medicine at The Universidad de San Carlos de Guatemala in 1982.
  • He finished a Neurology Residency in 1995 at the Loma Linda University Medical Center in Loma Linda, CA.
  • Dr. Matus is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN).

Certain Virtus Closed-End Funds Name Ethan Turner as Portfolio Manager

Retrieved on: 
星期五, 一月 27, 2023

HARTFORD, Conn., Jan. 27, 2023 /PRNewswire/ -- Seven Virtus closed-end funds that are subadvised by Voya Investment Management (Voya IM) announced that Ethan Turner has been appointed as a portfolio manager, effective today.

Key Points: 
  • HARTFORD, Conn., Jan. 27, 2023 /PRNewswire/ -- Seven Virtus closed-end funds that are subadvised by Voya Investment Management (Voya IM) announced that Ethan Turner has been appointed as a portfolio manager, effective today.
  • Turner, who is a vice president on the income and growth strategies team at Voya IM, joins as a member of the portfolio management team of each of Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), Virtus Convertible & Income 2024 Target Term Fund (NYSE: CBH), Virtus Convertible & Income Fund (NYSE: NCV), Virtus Convertible & Income Fund II (NYSE: NCZ), Virtus Diversified Income & Convertible Fund (NYSE: ACV), Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ), and Virtus Equity & Convertible Income Fund (NYSE: NIE).
  • He joined Voya IM in 2022 following the firm's acquisition of a substantial majority of Allianz Global Investors' (AllianzGI) U.S. business.
  • At AllianzGI, Turner was an analyst and vice president with research responsibilities for the income and growth strategies team.

HILTI TO ADD MORE THAN 30 NEW CORDLESS TOOLS TO ALL-ON-ONE NURON BATTERY PLATFORM

Retrieved on: 
星期二, 一月 10, 2023

With a multitude of tools that span across a variety of trades, Hilti extends solutions for applications in formwork, pipe hanging and metal cutting.

Key Points: 
  • With a multitude of tools that span across a variety of trades, Hilti extends solutions for applications in formwork, pipe hanging and metal cutting.
  • "Transitioning from gas or corded to the Nuron all-on-one cordless platform with Hilti reduces tool crib complexity, without compromising on performance," said Mike McGowan, Region Head and CEO of Hilti North America.
  • "And Nuron continues to enable businesses to make informed decisions using real-time jobsite data obtained from its cloud-connected, intelligent cordless tools and batteries."
  • Hilti diamond and carbide blades and drill bits are designed specifically for Hilti Nuron cordless tools to increase system performance or extend the life of the power tool accessories.

Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium on ALS/MND

Retrieved on: 
星期一, 十二月 5, 2022

BOTHELL, Wash., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today presented data highlighting the potential therapeutic benefits of ATH-1105, a small molecule positive modulator of the HGF/MET neurotrophic system, in a preclinical mouse model of amyotrophic lateral sclerosis (ALS). The findings were presented at the Motor Neurone Disease Association’s 33rd International Symposium on ALS/MND.

Key Points: 
  • The findings were presented at the Motor Neurone Disease Association’s 33rd International Symposium on ALS/MND.
  • Athira aims to provide rapid cognitive improvement and alter the course of neurological diseases with its novel mechanism of action.
  • These forward-looking statements speak only as of the date hereof and Athira undertakes no obligation to update forward-looking statements.
  • Athira may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on the forward-looking statements.

High Tide Becomes Top Revenue-Generating Cannabis Company in Canada

Retrieved on: 
星期二, 十一月 22, 2022

According to New Cannabis Ventures, we are now the highest Canadian revenue-generating cannabis company across all three verticals of retail, extraction and growing.

Key Points: 
  • According to New Cannabis Ventures, we are now the highest Canadian revenue-generating cannabis company across all three verticals of retail, extraction and growing.
  • This opening marks High Tides 142nd Canna Cabana branded retail cannabis location in Canada and is the 44th location in Ontario.
  • In addition, High Tide announces the grant of an aggregate of 15,000 incentive stock options (the Options) to certain employees of the Company.
  • High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets.